Clinical Trial Results

Showing: All studies [change]
Condition: COPD Location: Cherry Hill, New Jersey 23 trials found
New Search
Filter
Trial Phase
Study Type
COPD Exacerbation Follow Up
N/AOBSERVATIONAL Park Ridge, Illinois +4 more
RECRUITING
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
PHASE3INTERVENTIONAL Sheffield, Alabama +4 more
RECRUITING
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
PHASE3INTERVENTIONAL Athens, Alabama +4 more
RECRUITING
Supporting Evidence-based Responses to Emotional Needs in Emphysema
NAINTERVENTIONAL Detroit, Michigan +1 more
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
PHASE3INTERVENTIONAL Foley, Alabama +4 more
RECRUITING
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Temple Health Chest Initiative (THCI 2.0)
N/AOBSERVATIONAL Philadelphia, Pennsylvania
RECRUITING
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
NAINTERVENTIONAL Birmingham, Alabama +3 more
RECRUITING
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
SPIROMICS Study of Early COPD Progression (SOURCE)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
N/AOBSERVATIONAL Philadelphia, Pennsylvania
RECRUITING
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
PHASE4INTERVENTIONAL Mullica Hill, New Jersey
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
PHASE3INTERVENTIONAL Bakersfield, California +4 more
RECRUITING
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
PHASE3INTERVENTIONAL Newport Beach, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type